EDAP May 2024 7.500 call
| Previous close | 0.2000 |
| Open | 0.2500 |
| Bid | 0.1000 |
| Ask | 0.3000 |
| Strike | 7.50 |
| Expiry date | 2024-05-17 |
| Day's range | 0.2000 - 0.2500 |
| Contract range | N/A |
| Volume | |
| Open interest | 270 |
Simply Wall St.EDAP TMS S.A.'s (NASDAQ:EDAP) top owners are individual investors with 56% stake, while 24% is held by institutions
Key Insights Significant control over EDAP TMS by individual investors implies that the general public has more power...
GlobeNewswireEDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy During Plenary Session at the 119th American Urological Association (AUA) Annual Meeting
Final results demonstrate a significantly higher salvage treatment free survival rate (STFS) at 30 months of 89.6% in the HIFU-treated arm versus 86.2% in patients who underwent radical prostatectomy (RP) Functional evaluation criteria show better results with respect to urinary continence and erectile function in patients receiving HIFU therapy versus patients receiving RP Final study results were presented during a plenary session of the AUA focused on paradigm-shifting and practice-changing c
Globe NewswireEDAP to Announce First Quarter 2024 Financial Results on May 16, 2024
Company to host conference call and webcast on Thursday, May 16th at 8:30am EDT LYON, France, May 2, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the first quarter ended March 31, 2024, before the markets open on Thursday, May 16th, 2024. An accompanying conference call and webcast will be conducted by Ryan Rhodes, Chief Executive Officer, Ken Mobeck, Chief Financial Officer
